In other news, earlier in its Q3 2025 earnings report, UniQure detailed promising clinical data for its lead gene therapy ...
Aurora Innovation Inc. (NASDAQ: AUR) is one of the stocks that will double in 2026. On December 9, Itay Michaeli from TD ...
ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) is a clinical-stage biopharmaceutical company that discovers and develops therapies ...
Evolent Health Inc. (NYSE: EVH) is one of the stocks that will double in 2026. On November 21, Citi lowered the firm’s price ...
Amdocs Limited (NASDAQ:DOX) is one of the best affordable AI stocks to buy now. Amdocs Limited (NASDAQ:DOX) commands a ...
Earlier in its Q3 2025 earnings report, Evolus achieved global net revenue of $69 million, which marked a 13% increase ...
In Q3 2025, Viking Therapeutics highlighted significant progress in its obesity pipeline, particularly for the dual GLP-1/GIP ...
Recently, on December 8, Tyler Radke from Citi reiterated a Buy rating on the stock and lowered its price target from $310 ...
Gorilla Technology Group Inc. (NASDAQ: GRRR) is one of the best affordable AI stocks to buy now. On December 10, Northland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback